Cargando…
Oncolytic Virotherapy in Peritoneal Metastasis Gastric Cancer: The Challenges and Achievements
Gastric cancer (GC) is the fourth most common cancer and the second leading cause of cancer death globally. Although the mortality rate in some parts of the world, such as East Asia, is still high, new treatments and lifestyle changes have effectively reduced deaths from this type of cancer. One of...
Autores principales: | Shao, Su, Yang, Xue, Zhang, You-Ni, Wang, Xue-Jun, Li, Ke, Zhao, Ya-Long, Mou, Xiao-Zhou, Hu, Pei-Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918680/ https://www.ncbi.nlm.nih.gov/pubmed/35295845 http://dx.doi.org/10.3389/fmolb.2022.835300 |
Ejemplares similares
-
Editorial: Oncolytic virotherapy
por: Al-Shammari, Ahmed Majeed, et al.
Publicado: (2023) -
Oncolytic Virotherapy in Solid Tumors: The Challenges and Achievements
por: Jin, Ke-Tao, et al.
Publicado: (2021) -
A Three-Dimensional Organoid Model of Primary Breast Cancer to Investigate the Effects of Oncolytic Virotherapy
por: Carter, Mary E., et al.
Publicado: (2022) -
ONCOLYTIC VIROTHERAPY
por: Russell, Stephen J, et al.
Publicado: (2012) -
Progress of oncolytic virotherapy for neuroblastoma
por: Chen, Xiao-Tong, et al.
Publicado: (2022)